Abstract
Nicotine is known to release neuroendocrine substances which may subsequently reinforce smoking behavior by improving mood states. The purpose of this study was to examine changes in plasmaβ-endorphin and mood states during periods of chronic smoking, abstinence from smoking, and abstinence while chewing nicotine gum. A modified A-B-A-C design was used. Normal male volunteers were randomly assigned to an experimental or control group. Over a 12-day protocol, experimental subjects smoked ad libitum for 2 days, were abstinent for 4 days, resumed smoking for 2 days, and then chewed nicotine gum for the final 4 days. Control subjects smoked ad libitum throughout the entire protocol. Results indicated that changes in plasmaβ-endorphin levels were not related to changes in the four smoking conditions. Plasma nicotine and mood states were related, such that dysphoric moods increased during abstinence from smoking in comparison to the control group. To investigate further the relationships between nicotine,β-endorphin and reinforcement for smoking, it may be necessary to characterize endogenous opioid peptide release in the central nervous system during smoking.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cahill CA, Matthews JD, Akil H (1983) Human plasma beta-end-orphin-like peptides: a rapid high recovery extraction technique and validation of radioimmunoassay. J Clin Endocrinol Metab 56: 992–997
Fertig J, Pomerleau O, Sanders B (1986) Nicotine-produced anti-nociception in minimally deprived smokers and ex-smokers. Addict Behav 11: 239–248
Frederikson RCA (1984) Endogenous opioids and related derivatives. In Kuhar MJ, Pasternak GW (eds) Analgesics: neurochemical, behavioral, and clinical perspectives. Raven Press, New York
Gilbert DG, Meliska CJ, Williams CL, Jensen RA (1992) Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology 106: 275–281
Gorelick DA, Rose J, Jarvik ME (1989) Effect of naloxone on cigarette smoking. J Subst Abuse 1: 153–159
Gottlieb A, Killen J, Marlatt GA, Taylor CB (1987) Psychological and pharmacological influences in cigarette smoking withdrawal: effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse. J Consult Clin Psychol 55: 606–608
Hariharan M, VanNoord T, Greden JF (1988) A high-performance liquid chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clin Chem 34: 724–729
Hatsukami DK, Hughes JR, Pickens RW, Svikis D (1984) Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology 84: 231–236
Hatsukami, JW, Hughes JR, Pickens RW (1985) Characterization of tobacco withdrawal: physiological and subjective effects. NIDA Res Monogr Ser 53: 56–67
Hughes JR, Hatsukami DK, Pickens RW, Svikis D (1984) Consistency of the tobacco withdrawal syndrome. Addict Behav 9: 409–412
Jarvis MJ, Russell MAH, Saloojee Y (1980) Expired air carbon monoxide: a simple test of tobacco smoke intake. BMJ 281: 484–485
Jensen RA, Gilbert DG, Meliska CJ, Landrum TA (1990) Characterization of a dose-response curve for nicotine-induced conditioned taste aversion in rats: relationship to elevation of plasmaβ-endorphin concentration. Behav Neural Biol 53: 428–440
Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27: 1541–1545
Keppel G (1982) Design and analysis: a researcher's handbook. Prentice-Hall, Englewood Cliffs
McNair DM, Lorr M, Droppleman LF (1971) ETIS manual for the profile of mood states. Education and Industrial Testing Service, San Diego
Pomerleau OF, Pomerleau CS (1984) Neuroregulators and the reinforcement of smoking: toward a biobehavioral explanation. Neurosci Biobehav Rev 8: 503–513
Pomerleau OF, Fertig J, Seyler LE, Jaffe J (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81: 61–67
Pomerleau O, Turk D, Fertig B (1984) The effects of cigarette smoking on pain and anxiety. Addict Behav 9: 265–271
Rose, JE, Ananda S, Jarvik ME (1983) Cigarette smoking during anxiety-provoking and monotonous tasks. Addict Behav 8: 353–359
Sahley TL, Berntson GG (1979) Antinociceptive effects of central and systemic administration of nicotine in the rat. Psychopharmacology 65: 279–283
Schneider N, Jarvik ME (1985) Nicotine gum vs. placebo gum: comparisons of withdrawal symptoms and success rates. NIDA Res Monogr 53: 83–101
Seyler LE, Pomerleau OF, Fertig JB, Hunt D, Parker K (1986) Pituitary hormone response to cigarette smoking. Pharmacol Biochem Behav 24: 159–162
Shiffman S (1979) The tobacco withdrawal syndrome. NIDA Res Monogr 23: 158–184
Shiffman S, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50: 35–39
Tejwani GA (1981) Pharmacologic and other effects of opiate agonists and antagonists. Recent Adv Clin Ther 1: 193–216
Tejwani GA, Vaswani KK, Barbacci JC, Richard CW, Bianchine JR (1983) Effect of oral contraceptives on rat brain and pituitary beta-endorphin. Life Sci 33: 519–522
Transdermal Nicotine Study Group (1991) Transdermal nicotine for smoking cessation: Six-month results from two multicenter controlled clinical trials. JAMA 266: 3133–3138
Tripathi HL, Martin BR, Aceto MD (1982) Nicotine-induced anti-nociception in rats and mice: correlation with nicotine brain levels. J Pharmacol Exp Ther 221: 91–96
United States Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction. Government Printing Office. Washington
Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wewers, M.E., Tejwani, G.A. & Anderson, J. Plasma nicotine, plasma β-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement. Psychopharmacology 116, 98–102 (1994). https://doi.org/10.1007/BF02244878
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244878